Literature DB >> 10590149

Measles virus induces functional TRAIL production by human dendritic cells.

P O Vidalain1, O Azocar, B Lamouille, A Astier, C Rabourdin-Combe, C Servet-Delprat.   

Abstract

Measles virus infection induces a profound immunosuppression that can lead to serious secondary infections. Here we demonstrate that measles virus induces tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) mRNA and protein expression in human monocyte-derived dendritic cells. Moreover, measles virus-infected dendritic cells are shown to be cytotoxic via the TRAIL pathway.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10590149      PMCID： PMC111571          DOI： 10.1128/jvi.74.1.556-559.2000

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  15 in total

1.  Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

Authors:  H Walczak; R E Miller; K Ariail; B Gliniak; T S Griffith; M Kubin; W Chin; J Jones; A Woodward; T Le; C Smith; P Smolak; R G Goodwin; C T Rauch; J C Schuh; D H Lynch
Journal:  Nat Med       Date:  1999-02       Impact factor: 53.440

2.  TRAIL/Apo-2-ligand-induced apoptosis in human T cells.

Authors:  I Jeremias; I Herr; T Boehler; K M Debatin
Journal:  Eur J Immunol       Date:  1998-01       Impact factor: 5.532

3.  Identification and characterization of a new member of the TNF family that induces apoptosis.

Authors:  S R Wiley; K Schooley; P J Smolak; W S Din; C P Huang; J K Nicholl; G R Sutherland; T D Smith; C Rauch; C A Smith
Journal:  Immunity       Date:  1995-12       Impact factor: 31.745

4.  Induction of maturation of human blood dendritic cell precursors by measles virus is associated with immunosuppression.

Authors:  J J Schnorr; S Xanthakos; P Keikavoussi; E Kämpgen; V ter Meulen; S Schneider-Schaulies
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

5.  Differential regulation of TRAIL and CD95 ligand in transformed cells of the T and B lymphocyte lineage.

Authors:  S M Mariani; P H Krammer
Journal:  Eur J Immunol       Date:  1998-03       Impact factor: 5.532

6.  Mechanism of suppression of cell-mediated immunity by measles virus.

Authors:  C L Karp; M Wysocka; L M Wahl; J M Ahearn; P J Cuomo; B Sherry; G Trinchieri; D E Griffin
Journal:  Science       Date:  1996-07-12       Impact factor: 47.728

7.  Measles virus infection induces terminal differentiation of human thymic epithelial cells.

Authors:  H Valentin; O Azocar; B Horvat; R Williems; R Garrone; A Evlashev; M L Toribio; C Rabourdin-Combe
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

8.  Measles virus infection enhances IL-1 beta but reduces tumor necrosis factor-alpha expression in human monocytes.

Authors:  R Leopardi; R Vainionpää; M Hurme; P Siljander; A A Salmi
Journal:  J Immunol       Date:  1992-10-01       Impact factor: 5.422

9.  Measles virus infects human dendritic cells and blocks their allostimulatory properties for CD4+ T cells.

Authors:  I Grosjean; C Caux; C Bella; I Berger; F Wild; J Banchereau; D Kaiserlian
Journal:  J Exp Med       Date:  1997-09-15       Impact factor: 14.307

10.  Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine, TRAIL.

Authors:  T S Griffith; S R Wiley; M Z Kubin; L M Sedger; C R Maliszewski; N A Fanger
Journal:  J Exp Med       Date:  1999-04-19       Impact factor: 14.307
View more
  57 in total

1.  Respiratory syncytial virus infection sensitizes cells to apoptosis mediated by tumor necrosis factor-related apoptosis-inducing ligand.

Authors:  Alexander Kotelkin; Elena A Prikhod'ko; Jeffrey I Cohen; Peter L Collins; Alexander Bukreyev
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

2.  The magnitude of the T cell response to a clinically significant dose of influenza virus is regulated by TRAIL.

Authors:  Erik L Brincks; Prajwal Gurung; Ryan A Langlois; Emily A Hemann; Kevin L Legge; Thomas S Griffith
Journal:  J Immunol       Date:  2011-09-21       Impact factor: 5.422

Review 3.  Innate lymphocyte and dendritic cell cross-talk: a key factor in the regulation of the immune response.

Authors:  A Reschner; P Hubert; P Delvenne; J Boniver; N Jacobs
Journal:  Clin Exp Immunol       Date:  2008-03-10       Impact factor: 4.330

4.  CD8 T cells utilize TRAIL to control influenza virus infection.

Authors:  Erik L Brincks; Arna Katewa; Tamara A Kucaba; Thomas S Griffith; Kevin L Legge
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

5.  The human papillomavirus type 16 E5 protein impairs TRAIL- and FasL-mediated apoptosis in HaCaT cells by different mechanisms.

Authors:  Kirsten Kabsch; Angel Alonso
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

6.  Antitumor and immunostimulatory activities of a genotype V recombinant attenuated veterinary Newcastle disease virus vaccine.

Authors:  Oscar Antonio Ortega-Rivera; J Luis Quintanar; Susana Del Toro-Arreola; Ángel G Alpuche-Solis; Mayra J Esparza-Araiza; Eva Salinas
Journal:  Oncol Lett       Date:  2017-11-09       Impact factor: 2.967

7.  Induction of cell death in human immunodeficiency virus-infected macrophages and resting memory CD4 T cells by TRAIL/Apo2l.

Authors:  J J Lum; A A Pilon; J Sanchez-Dardon; B N Phenix; J E Kim; J Mihowich; K Jamison; N Hawley-Foss; D H Lynch; A D Badley
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

Review 8.  The TRAIL to viral pathogenesis: the good, the bad and the ugly.

Authors:  Nathan Cummins; Andrew Badley
Journal:  Curr Mol Med       Date:  2009-05       Impact factor: 2.222

9.  A subset of myeloid dendritic cells derived from peripheral blood monocytes represented a predominant subset characterized by their potential tumor-inhibiting activity.

Authors:  Min Wang; Jun Shi; Yun Wan; Jing Li; Yinghua Yuan
Journal:  In Vitro Cell Dev Biol Anim       Date:  2009-03-14       Impact factor: 2.416

10.  Toll-like receptors, chemokine receptors and death receptor ligands responses in SARS coronavirus infected human monocyte derived dendritic cells.

Authors:  Helen K W Law; Chung Yan Cheung; Sin Fun Sia; Yuk On Chan; J S Malik Peiris; Yu Lung Lau
Journal:  BMC Immunol       Date:  2009-06-08       Impact factor: 3.615
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.